Zygomatic and Pterygoid Implants Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Length (Upto 30 mm, 30 - 50 mm, Above 50 mm), By Application (Maxillary Sinuses, Severe Atrophy of Maxillary Bone, Other), By End User (Hospitals, Dental Clinics, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 276.21 Million
CAGR (2026-2031)	6.58%
Fastest Growing Segment	Hospitals
Largest Market	North America
Market Size (2031)	USD 404.85 Million

Market Overview

The Global Zygomatic and Pterygoid Implants Market will grow from USD 276.21 Million in 2025 to USD 404.85 Million by 2031 at a 6.58% CAGR. Zygomatic and pterygoid implants are specialized, extended-length dental fixtures anchored in the zygomatic bone or pterygoid plates, designed to facilitate the rehabilitation of the severely atrophic maxilla without requiring extensive bone grafting. The primary drivers supporting market growth include an expanding geriatric population and a distinct patient preference for immediate loading protocols that reduce treatment duration compared to traditional augmentation methods. According to the American Academy of Implant Dentistry, in 2025, it was reported that more than 3 million Americans possess dental implants, a number increasing by approximately 500,000 annually, underscoring the rising demand for restorative dental solutions.

However, a significant challenge impeding broader market expansion is the steep learning curve associated with these complex surgical procedures. The placement of these implants requires advanced anatomical knowledge and surgical precision to avoid severe complications such as orbital injury or chronic sinusitis, thereby restricting the availability of qualified practitioners to perform these rehabilitations.

Key Market Drivers

The expanding global geriatric population susceptible to bone resorption is a primary force propelling the adoption of zygomatic and pterygoid implants. As individuals age, the likelihood of severe maxillary atrophy and complete tooth loss increases significantly, often rendering traditional endosseous implants unviable without complex grafting. Zygomatic fixtures offer a critical graft-less solution for these elderly patients by anchoring into the dense zygoma bone, thereby bypassing the resorbed maxilla and reducing surgical trauma. According to the World Health Organization, March 2025, in the 'Oral health' report, a global edentulism prevalence of 23% has been estimated for people aged 60 years or older, highlighting the vast target demographic requiring these specialized rehabilitation solutions.

Technological advancements in digital planning and computer-guided surgery are further accelerating market growth by mitigating the inherent risks of these complex procedures. The integration of 3D imaging and guided protocols enhances surgical precision, allowing clinicians to place extended-length implants with greater accuracy and confidence, which is essential given the proximity to vital anatomical structures like the orbit. This shift toward digitized workflows is driving substantial commercial activity within the sector. According to Straumann Group, August 2025, in the '2025 Half-Year Report', the company achieved 10.2% organic revenue growth, a performance largely supported by the rising adoption of digital workflows and implantology. Furthermore, the commercial scale of the broader dental technology market remains robust; according to Dentsply Sirona, in 2025, the company reported third-quarter net sales of $904 million, underscoring the significant financial investment fueling these innovative restorative solutions.

Download Free Sample Report

Key Market Challenges

The steep learning curve associated with zygomatic and pterygoid implants constitutes a formidable barrier to market entry, significantly restricting the number of dental professionals qualified to perform these procedures. Unlike conventional implantology, these complex rehabilitations demand a profound mastery of craniofacial anatomy and high-level surgical precision to navigate hazardous zones near the orbit and pterygomaxillary fissure. The inherent risks of severe complications, such as orbital penetration or nerve damage, deter the vast majority of general dentists from adopting these techniques, thereby confining the availability of treatment to a narrow niche of specialized surgeons.

This scarcity of skilled practitioners creates a critical supply-side bottleneck that directly impedes the market's ability to scale. The rigorous training and expertise required to manage such cases are reflected in the low number of professionals attaining top-tier certification. According to the American Board of Prosthodontists, in 2024, only 50 new Diplomates achieved certification, highlighting the limited expansion of the workforce capable of executing or overseeing such complex restorative solutions. This shortage of certified experts forces patients to face limited access and long waiting periods, effectively stalling procedure volumes and hampering the overall growth potential of the market despite rising patient demand.

Key Market Trends

The integration of dynamic surgical navigation and robotic assistance is fundamentally altering the surgical workflow for complex craniofacial rehabilitations. These technologies offer real-time haptic feedback and visualization, which are critical when anchoring fixtures in the dense zygomatic bone or pterygoid plates where visibility is limited and precision is paramount to avoid vital structures like the orbit. By minimizing the risk of neurovascular injury and reducing physical strain, these automated systems are encouraging broader clinician adoption and increasing case acceptance. According to Neocis, September 2024, in the 'Yomi Robotic Dental Implant System Drives Increased Implant Volume and Practice Profitability According to Growth Study', dental practices implementing the Yomi robotic system achieved an average implant volume growth of 137% within one year, illustrating the significant commercial and operational impact of this technological integration.

Concurrently, there is a distinct market shift towards the development of patient-specific and custom 3D-printed implants, particularly for cases of extreme maxillary atrophy where standard zygomatic configurations may be insufficient. Utilizing Direct Metal Laser Sintering (DMLS), manufacturers can now fabricate titanium subperiosteal frameworks that perfectly match the patient's residual anatomy, offering a viable graft-less alternative for patients with compromised bone volume. This customization trend is driving significant segment revenue as demand for personalized solutions accelerates globally. According to Materialise, October 2025, in the 'Materialise Reports Third Quarter 2025 Results', the company’s Medical segment, which encompasses customized implant solutions, reported a revenue increase of 10.3% to €33.3 million compared to the prior year, highlighting the robust expansion of the patient-specific restorative market.

Segmental Insights

The Hospitals segment is currently emerging as the fastest-growing category in the Global Zygomatic and Pterygoid Implants Market, primarily due to its capacity to handle complex medical cases. These institutions provide the advanced surgical infrastructure and general anesthesia capabilities necessary for treating patients with severe maxillary atrophy or maxillofacial trauma. Furthermore, hospitals offer access to multidisciplinary teams that ensure comprehensive perioperative care and safety for high-risk procedures. This expansion is also supported by favorable reimbursement frameworks for hospital-based surgeries, which increasingly drive patient volume toward these facilities for extensive oral rehabilitation.

Regional Insights

North America holds the leading share in the global zygomatic and pterygoid implants market, attributed to the high adoption of specialized dental rehabilitation procedures. This dominance is supported by a robust healthcare infrastructure and a growing geriatric demographic requiring complex maxillary reconstruction. Additionally, the region benefits from the presence of key industry manufacturers and established regulatory frameworks, such as those maintained by the U.S. Food and Drug Administration, which ensure product safety and market accessibility. Rising patient demand for immediate function solutions further strengthens the regional market position.

Recent Developments

• In September 2025, the Straumann Group released the results of a three-year prospective study validating the long-term success of its zygomatic implant system combined with the anatomy-guided approach (ZAGA). The research reported a 100% survival rate for both the implants and the prosthetic restorations in patients with severe maxillary atrophy. The study results demonstrated that the company's solution, which includes specific flat and round implant designs to match patient anatomy, provided predictable and stable outcomes without the need for extensive bone grafting. This breakthrough data reinforced the clinical efficacy of the company's portfolio for edentulous patients.
• In October 2024, Southern Implants collaborated with leading experts to host the inaugural Global Zygomatic Complications Symposium in New York City. This event brought together international dental professionals to discuss the prevention and management of complications associated with zygomatic and pterygoid implants. The symposium featured in-depth case studies and expert-led sessions, focusing on advanced clinical strategies and the company's specialized implant designs. This initiative highlighted the company's dedication to fostering industry collaboration and improving patient safety standards in the field of remote anchorage solutions.
• In September 2024, JDentalCare introduced the Z-GO Guide, a patented surgical guide system specifically engineered for zygomatic implant procedures. This new product was designed to enhance the precision and predictability of complex surgeries involving severe bone loss in the upper jaw. The system utilized advanced digital planning software and 3D laser-printing technology to create a bone-supported guide that assisted clinicians in accurate implant placement. The launch aimed to improve safety and simplify the surgical workflow for the company's zygomatic implant range, catering to the growing demand for guided surgery solutions in the market.
• In May 2024, Nobel Biocare launched the Zygoma Academy, a specialized educational initiative designed to advance clinical proficiency in zygomatic implant treatments. This program was established to provide dental professionals with comprehensive training on the company's zygomatic solutions, addressing the complexities of treating patients with severe maxillary atrophy. The academy offered a tiered learning structure, including one-on-one mentorships and small-group sessions, facilitating peer-to-peer knowledge sharing and skill development. This development underscored the company's commitment to supporting the clinical community with high-level educational resources for complex rehabilitation procedures.

Key Market Players

• Straumann Holding AG
• Noris Medical
• S.I.N. Implant System
• Southern Implants (Pty) Ltd
• IDC Implant & Dental Company
• Danaher Corporation
• Bioline Dental Implant Systems Ltd

By Product Length	By Application	By End User	By Region
Upto 30 mm 30 - 50 mm Above 50 mm	Maxillary Sinuses Severe Atrophy of Maxillary Bone Other	Hospitals Dental Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Zygomatic and Pterygoid Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Zygomatic and Pterygoid Implants Market, By Product Length:

• Upto 30 mm
• 30 - 50 mm
• Above 50 mm

• Zygomatic and Pterygoid Implants Market, By Application:

• Maxillary Sinuses
• Severe Atrophy of Maxillary Bone
• Other

• Zygomatic and Pterygoid Implants Market, By End User:

• Hospitals
• Dental Clinics
• Others

• Zygomatic and Pterygoid Implants Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE